Brewin Dolphin LTD Summit Therapeutics Inc. Transaction History

Brewin Dolphin LTD

  • $2.08 Billion
  • Q2 2022

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Nov 09, 2023
BUY
$5.15 - $8.46 $2,811 - $4,619
546 Added 17.22%
3,716 $27.7 Million
Q1 2021

Nov 09, 2023
BUY
$5.17 - $11.19 $6,204 - $13,428
1,200 Added 60.91%
3,170 $18.6 Million
Q4 2020

Nov 09, 2023
BUY
$3.25 - $6.0 $6,402 - $11,820
1,970 New
1,970 $9.26 Million

Others Institutions Holding SMMT

# of Institutions
232
Shares Held
83.1M
Call Options Held
1.66M
Put Options Held
2.56M
View Full List

About Summit Therapeutics Inc.

SMMT Quotes by TradingView
  • Ticker SMMT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 201,215,008
  • Market Cap $4.45B
  • Description
  • Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...
More about SMMT
Track This Portfolio

Track Brewin Dolphin LTD Portfolio

Follow Brewin Dolphin LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brewin Dolphin LTD, based on Form 13F filings with the SEC.

News

Stay updated on Brewin Dolphin LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email